Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Gianni L, Pienkowski T, Im YH. et al
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.

Lancet Oncol 2012;
13 (01) 25-32

Bibliographische Angaben herunterladen

Aufrufen in: